OCC fundamentals
Key facts
Market capitalization310.94 MAUD
Basic EPS (TTM)−0.02AUD
Founded2006
CEOPaul Frederick Anderson
Websiteorthocell.com
About
Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. Its products include CelGro, which is a naturally derived collagen medical device for soft tissue repair; and Antilogous Tenocyte Implantation for chronic treatment resistant tendon injuries. The company was founded by Paul Frederick Anderson and Ming Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−515%
−395%
−275%
−155%
−35%
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−6.00 M
−3.00 M
0.00
3.00 M
6.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
No dividends
OCC has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company